Feature | April 19, 2011

April 19, 2011 – Andrew Einstein delivered the Douglas P. Zipes Distinguished Young Scientist Award Lecture entitled "Effects of Radiation Exposure During Cardiac Imaging: How Good Is the Data?" at this year's American College of Cardiology annual scientific sessions. The field of cardiac computed tomography (CT) angiography has been proactive and responsible in developing and employing significant radiation sparing techniques in response to the concerns raised by Einstein and others.


The Society of Cardiovascular Computed Tomography (SCCT) considers radiation exposure during imaging a matter of utmost importance and supports the tremendous amount of work by vendors and clinicians to reduce unnecessary radiation exposure from diagnostic cardiac CT angiography. Firstly, the SCCT verification program supports the rigorous published cardiac CT training guidelines, which mandate extensive education in radiation safety and radiation reduction techniques for all Level II and Level III certified clinicians. In fact, radiation exposure from cardiac CT has been reduced by about 80 percent (15 mSv to 3-4 mSv) through advances in technology, protocols and algorithms, especially within the last two or three years. The average radiation exposure dose for cardiac CT angiography is now equal to and often less than that of invasive diagnostic cardiac angiography and is substantially lower than that of cardiac SPECT (single photon emission computed tomography) and PET (positron emission tomography) imaging. Published reports document radiation doses for common cardiac diagnostic tests as follows: prospective (state of the art) CT angiography protocols: 2-4 mSv; retrospective (older) CT angiography protocols: 12-18 mSv; diagnostic invasive coronary angiography: 7 mSv. SPECT perfusion studies: 12 mS; average annual background radiation exposures (United States): 3 mSv.


A 2010 article by Raff et al entitled "Radiation dose from coronary CT angiography: Five years of progress (published in the Journal of Cardiovascular Computed Tomography, Vol. 4, No. 6, November/December 2010) demonstrates the significant radiation reductions resulting from advances in the field. This point is illustrated by the following figure from his article (reproduced with the permission of Elsevier (Copyright Elsevier 2010).


Figure 1 (B) Radiation dose by year. Blue symbols indicate research reports by publication date; blue line, linear regression of reported research doses; red squares, multicenter clinical reported doses listed by year data collected; red line, linear regression of reported clinical survey doses.


In addition, preliminary data suggest that cardiac CT angiography may reduce the number of unnecessary SPECT and invasive angiographic studies. The SCCT also supports the inclusion of radiation dose reporting in the same document as the clinical report.


Further work in this area is ongoing and there have been more recent publications, including abstracts at these very scientific sessions, documenting the effectiveness of these radiation-sparing techniques.


The SCCT recommends that diagnostic radiation be utilized judiciously, in line with the principles of ALARA (as low as reasonably achievable) and that it be individualized to each patient, weighing the radiation exposure risk versus diagnostic testing benefit. Diagnostic radiation should only be prescribed when the benefits of a particular test are felt to outweigh any potential harm from the resulting radiation exposure. In addition, the SCCT recommends following the published guidelines and appropriate use criteria regarding indications for diagnostic and screening cardiac imaging studies.


Matthew Budoff, M.D., FSCCT, professor of medicine, Los Angeles Biomedical Research Institute, SCCT president adds, "We [SCCT] vigorously support awareness of radiation safety and the adoption of a policy of responsible diagnostic radiation use. We encourage ongoing efforts to continue the excellent work taking place in the area of diagnostic radiation reduction techniques and radiation exposure monitoring. We are encouraged that the increased awareness has led to improvements in patient dose. Most of our members have reported dose reductions up to 70 percent at their institutions for cardiac CT angiography."


For more information: www.SCCT.org


Related Content

Navidea, Mass General, Tc99m-tilmanocept, vulnerable plaque, cardiovascular disease, Harvard
News | Radiopharmaceuticals and Tracers| July 30, 2015
Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of Tc99m-tilmanocept...
MSCs, stem cells, end-stageheart failure, retrograde, coronary sinus,
News | Stem Cell Therapies| July 29, 2015
A new clinical trial to test how a high dose of stem cells delivered via a method called retrograde coronary sinus...
Guerbet, acquisition, Mallinckrodt, CMDS business, contrast media, CT, MRI
News | Contrast Media| July 29, 2015
Guerbet announced that it has entered into a definitive agreement under which it will acquire Mallinckrodt's contrast...
heart failure, Adaptive CRT trial, AdaptivCRT algorithm, readmissions
News | Heart Failure| July 22, 2015
Heart failure patients had a significantly lower chance of being readmitted within 30 days of discharge when treated...
Direct Flow Medical, Transcatheter Aortic Valve System, SALUS Trial, FDA
News | Heart Valve Repair| July 22, 2015
Direct Flow Medical Inc. received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug...
Xarelto, anticoagulant protocol, discharge, outcomes, DVT, PE
News | Antiplatelet and Anticoagulation Therapies| July 21, 2015
Two companion papers published in Academic Emergency Medicine  address the question of when it is appropriate to...
UNC, biomarkers, severe heart disease, fructosamine, LDL cholesterol, Nichols
News | Cardiac Diagnostics| July 21, 2015
Insulin resistance affects tens of millions of Americans and is a big risk factor for heart disease. Yet, some people...
Feature | Atrial Fibrillation| July 20, 2015
A new study proves race and gender-related disparities exist in care for patients who have recently been diagnosed with...
Boston Scientific, fully absorbable scaffold, FAST study, resorbable
Feature | Stents Bioresorbable| July 20, 2015
Boston Scientific has initiated a study of the company's first fully resorbable drug-eluting scaffold system. The Fully...
Veryan Medical, BioMimics 3D femoropopliteal stent, MIMICS-2 study, PAD
News | Stents Peripheral| July 17, 2015
Veryan Medical announced that the first subject has been enrolled in their MIMICS-2 study at Universitäts-Herzzentrum...
Overlay Init